Fentanyl transdermal system CII patches, manufactured by Actavis, has been linked to serious, life-threatening side effects that include accidental overdoses and death.
What is the problem with Actavis Fentanyl Patch?
The Fentanyl Patch is intended for severe and chronic pain management that cannot be controlled by less powerful drugs. The Actavis Fentanyl Transdermal System releases Fentanyl through the skin for a time span of 72 hours. The patches may have a cut edge that could lead to the fentanyl gel leaking out and potential for overdose. The lots below covered by this recall have expiration dates between May 2009 and December 2009.
- Actavis Fentanyl Transdermal System, 25 mcg/hr. NDC 67767-120-18
- Actavis Fentanyl Transdermal System, 50 mcg/hr. NDC 67767-121-18
- Actavis Fentanyl Transdermal System, 75 mcg/hr. NDC 67767-122-18
- Actavis Fentanyl Transdermal System, 100 mcg/hr. NDC 67767-123-18
Side Effects of Actavis Fentanyl Patch
There are a variety of side effects associated with Actavis Fentanyl Patch. Our firm is pursing the following types of serious, life-threatening side effects:
- Possible Leaks
- Inadvertent Ingestion